(NASDAQ:MLTX), LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the […]

(NASDAQ:RIME), Largest Contract Expansion in Company's History, 10X Increase Over Initial Pilot Program Fort Lauderdale, FL, Dec. 11, 2025 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – a leading AI technology company, announced today that SemiCab has secured a major expansion of its Master Services Agreement with one of India's largest paint manufacturers

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Nokia CorporationStock Exchange Release11 December 2025 at 16:30 EET Correction: Changes in Nokia Corporation's own shares Espoo, Finland – the stock exchange release of Nokia Corporation titled “Changes in Nokia Corporation's Own Shares” published on 9 December 2025 incorrectly stated that the number of own shares held by Nokia Corporation following the transfer was

(SWX:HODL),(SWX:ABTC),(SWX:ABCH),(SWX:ABBA),(SWX:KEYS),(SWX:ABNB),(SWX:AETH),(SWX:AXRP),(SWX:AXTZ),(Paris:ABTC),(Paris:AETH),(Paris:SBTC),(Euronext Amsterdam:2BTC),(Euronext Amsterdam:BTCS),(Euronext Amsterdam:2ETH),(SWX:ADOT SE),(SWX:AADA SE),(SWX:AXLM SE),(SWX:SBTC SE),(LSE:ETHC LN),(LSE:CETU LN),(LSE:CBTC LN),(LSE:CBTU LN),(LSE:AETH LN),(LSE:ETHU LN),(LSE:BTCU LN),(LSE:ABTC LN),(Stockholm:AAVE),(Stockholm:HODL),(Stockholm:AADA),(Stockholm:ALINK),(Stockholm:ADOT),(Stockholm:HODLX),(NasdaqGM:TXXS), NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — 21shares, one of the world's largest issuers of cryptocurrency exchange traded products (ETPs), today announced the launch of the 21Shares XRP ETF (TOXR) on CBOE. The launch of TOXR provides investors

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire December 11, 2025 LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for

TailorCare Releases 2025 Year-End Results Showing Significant MSK Improvements and Lower Costs GlobeNewswire December 11, 2025 Nashville, TN, Dec. 11, 2025 (GLOBE NEWSWIRE) — TailorCare, a leading provider of value-based specialty musculoskeletal (MSK) care solutions accessible to more than 2.5 million eligible Medicare Advantage (MA) and commercial members, today released its 2025 Year-End Review highlighting

Correction: Changes in Nokia Corporation's own shares GlobeNewswire December 11, 2025 Nokia CorporationStock Exchange Release11 December 2025 at 16:30 EET Correction: Changes in Nokia Corporation's own shares Espoo, Finland – the stock exchange release of Nokia Corporation titled “Changes in Nokia Corporation's Own Shares” published on 9 December 2025 incorrectly stated that the number of

21shares Broadens US Spot Crypto Lineup with the Launch of XRP ETF (TOXR) GlobeNewswire December 11, 2025 NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — 21shares, one of the world's largest issuers of cryptocurrency exchange traded products (ETPs), today announced the launch of the 21Shares XRP ETF (TOXR) on CBOE. The launch of TOXR provides

SemiCab Awarded $6 Million Contract Expansion, Accelerating Projected ARR to Over $13 Million GlobeNewswire December 11, 2025 Largest Contract Expansion in Company's History, 10X Increase Over Initial Pilot Program Fort Lauderdale, FL, Dec. 11, 2025 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – a leading AI technology company, announced today that SemiCab has

Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets(TM) GlobeNewswire December 11, 2025 Delray Beach, FL, Dec. 11, 2025 (GLOBE NEWSWIRE) — Emerging markets, breakthrough technologies, and strategic M&A reshape competitive landscapeThe global molecular cytogenetics market is projected to reach USD 1.43 billion by 2030 from USD 1.02 billion in